Technology

Sohar Health Lands $3.8M to Open the Front Door to Faster, Fairer Care

Published

1 year ago

March 28, 2025

Kindred Capital backs Sohar Health’s mission to remove one of care’s biggest hidden barriers and create a seamless entry point for patients and providers

Sohar’s flagship Verification product is already powering millions of real-time insurance checks, helping leading providers reduce denials and get paid faster

The funding fuels growth for Sohar’s AI-first approach to eligibility and benefits verification, a long-overlooked gap in the revenue cycle that delays care and drains resources

NEW YORK, March 28, 2025 /PRNewswire/ — Sohar Health, an AI-driven eligibility determination and Verification of Benefits (VoB) provider, today announced a $3.8 million seed funding round led by Kindred Capital, with participation from Y Combinator, Rebel Fund, and Concept Ventures. The funding will accelerate Sohar’s mission to break down insurance barriers that delay care, overwhelm providers, and leave patients stuck in limbo.

Many patients run into roadblocks before they ever set foot in a clinic. For example, a parent might try to book a therapy appointment for their child, but the provider can’t confirm coverage. Or a patient with chronic pain might spend hours researching in-network specialists, only to be blindsided by a denial. These breakdowns, often the result of outdated directories or paperwork errors, are far from rare. In fact, 45% of insured, working-age adults report receiving medical bills for care they thought was covered. Six in ten delay treatment after a denial. A stronger, more accurate onboarding process could have prevented many of these issues before care was even delivered.

The ripple effects are measurable and costly. When insurance verification fails, patients delay or abandon care, contributing to the estimat ed $140 billion in unpaid medical debt in the U.S. Providers lose revenue and waste hours on rework: the average denial costs $118 to reprocess, and nearly one in five claims is denied at first submission. Delayed treatment can lead to worsening conditions and higher downstream costs, from avoidable ER visits to hospitalizations. On a broader scale, these failures fuel frustration and distrust, especially among vulnerable patients navigating chronic conditions or mental health concerns, eroding confidence in a system that already feels too complex to navigate.

To tackle these challenges, Sohar Health is rebuilding healthcare’s “front door” with real-time, AI-powered eligibility and benefits verification. Instead of wrestling with manual workflows and outdated systems, providers using Sohar can instantly confirm coverage, reduce administrative overhead, and see more patients. For patients, that means fewer delays, fewer denials, and a faster, clearer path to care.

Sohar’s flagship Verification product offers:

Real-Time Eligibility Checks: With a median response time of 6 seconds, 90% of eligibility verifications are completed within 30 seconds, seamlessly integrating into providers’ patient intake workflows.High Accuracy: Achieves a 96% accuracy rate in benefits data, including copay and coinsurance information, reducing claim denials and administrative errors.Bulk API Capabilities: Allows up to 1,000 verification checks per API call, ensuring patients maintain coverage from appointment scheduling to consultation.

“At Sohar Health, we believe the future of healthcare is seamless, efficient, and patient-focused,” said Ashish Mandavia, M.D., co-founder and CEO of Sohar Health. “With this funding, we are developing a product suite to help healthcare organizations streamline insurance workflows, allowing providers to focus on patient care rather than paperwork. The launch of Verification further strengthens access to care by eliminating administrative friction and improving the patient experience.”

By automating insurance eligibility verification, Sohar Health’s AI-powered solutions ensure patients get connected with the in-network care they need while increasing revenue capture for providers. The company’s solutions currently support leading behavioral health providers, primary care organizations, and telehealth platforms, ensuring that insurance verification no longer stands in the way of care.

“Fixing healthcare isn’t just about new treatments — it’s about modernizing the infrastructure that enables care to happen in the first place. Insurance verification is one of the most overlooked choke points in the revenue cycle, creating delays, denials, and massive inefficiencies for providers and patients alike,” said Leila Zegna, Founding Partner of Kindred Capital. “The founders of Sohar Health have the deep domain experience to tackle this space head-on, and their AI-powered solution has already earned the trust of leading healthcare providers and powering millions of verifications a year. We believe they’re building critical infrastructure for a more accessible, efficient healthcare system.”

To learn more about Sohar Health, visit https://www.soharhealth.com/

About Sohar Health

Founded by a physician and an engineer in 2023, Sohar Health is an AI-driven eligibility determination and Verification of Benefits (VoB) provider that’s redefining how healthcare organizations navigate the complex world of insurance claims. The team develops specialty-specific APIs to help providers reduce insurance claims denials, improve pricing transparency, and increase access to care for patients across the U.S. By harnessing the power of technology and uniquely understanding patients’ benefits coverage, Sohar Health’s eligibility service achieves above 90% accuracy, with around 95% of checks being returned within seconds. Learn more at www.soharhealth.com and follow us on LinkedIn and X.

Media Contact
Sohar Health
sohar@hermespr.co

View original content to download multimedia:https://www.prnewswire.com/news-releases/sohar-health-lands-3-8m-to-open-the-front-door-to-faster-fairer-care-302414445.html

SOURCE Sohar Health

Technology

MATSON ANNOUNCES ADDITION OF 3 MILLION SHARES TO EXISTING SHARE REPURCHASE PROGRAM AND QUARTERLY DIVIDEND OF $0.36 PER SHARE

Published

51 minutes ago

April 23, 2026

HONOLULU, April 23, 2026 /PRNewswire/ — The Board of Directors of Matson, Inc. (NYSE: MATX), a leading U.S. carrier in the Pacific, approved adding three million shares to its existing share repurchase program and extending the program to December 31, 2029. As of April 23, 2026, the existing share repurchase program had approximately 0.7 million shares remaining. The Board also declared a second quarter dividend of $0.36 per common share. The dividend will be paid on June 4, 2026 to all shareholders of record as of the close of business on May 7, 2026.

“We are pleased to announce an additional three million shares to our existing share repurchase program,” said Matt Cox, Matson’s Chairman and Chief Executive Officer. “Since we commenced our share repurchase program in August 2021, we have repurchased approximately 14.3 million shares, or approximately 33% of the then outstanding shares, for a total cost of $1.3 billion. Going forward, we will continue to be both disciplined and opportunistic in our capital allocation, and we remain committed to returning excess cash to shareholders to create additional shareholder value over the long-term.”

Shares will be repurchased in the open market from time to time at the Company’s discretion, based on ongoing assessments of the capital needs of the business, the market price of its common shares and general market conditions. The Company may enter into Rule 10b5-1 plans to facilitate purchases under the program. The repurchase program may be suspended or discontinued at any time.

About the Company

Founded in 1882, Matson (NYSE: MATX) is a leading provider of ocean transportation and logistics services. Matson provides a vital lifeline of ocean freight transportation services to the domestic non-contiguous economies of Hawaii, Alaska, and Guam, and to other island economies in Micronesia. Matson also operates premium, expedited services from China to Long Beach, California, which includes cargo from other Asia origins, provides services to Okinawa, Japan and various islands in the South Pacific, and operates an international export service from Alaska to Asia. The Company’s fleet of owned and chartered vessels includes containerships, combination container and roll-on/roll-off ships and barges. Matson Logistics, established in 1987, extends the geographic reach of Matson’s transportation network throughout North America and Asia. Its integrated logistics services include rail intermodal, highway brokerage, warehousing, freight consolidation, supply chain management, and freight forwarding to Alaska. Additional information about the Company is available at www.matson.com.

Forward Looking Statements

Statements in this news release that are not historical facts are “forward-looking statements,” within the meaning of the Private Securities Litigation Reform Act of 1995, that involve a number of risks and uncertainties that could cause actual results to differ materially from those contemplated by the relevant forward-looking statement, including but not limited to, statements about capital allocation plans, the timing, manner and volume of repurchases of common shares pursuant to the repurchase program, and use of excess cash. These forward-looking statements are not guarantees of future performance. This release should be read in conjunction with our Annual Report on Form 10-K and our other filings with the SEC through the date of this release, which identify important factors that could affect the forward-looking statements in this release. We do not undertake any obligation to update our forward-looking statements.

View original content to download multimedia:https://www.prnewswire.com/news-releases/matson-announces-addition-of-3-million-shares-to-existing-share-repurchase-program-and-quarterly-dividend-of-0-36-per-share-302752377.html

SOURCE Matson, Inc.

Technology

Accord Specialty Pharmacy Named Finalist in MMIT’s 11th Annual Retail Specialty Pharmacy Patient Choice Awards

Published

2 hours ago

April 23, 2026

ORLANDO, Fla., April 23, 2026 /PRNewswire/ — Accord Specialty Pharmacy, an independent specialty pharmacy serving patients across multiple states, has been named a finalist in the MMIT Patient Choice Awards, a recognition based on patient-reported satisfaction and experience.

Accord was selected as the only independent pharmacy among finalists in its category, alongside national pharmacy organizations such as Walgreens Specialty Pharmacy and Walmart Specialty Pharmacy. This distinction highlights the company’s commitment to delivering personalized, high-touch care for patients managing complex and chronic conditions.

The MMIT Patient Choice Awards recognize specialty pharmacies that demonstrate excellence in patient satisfaction, service quality, and overall care experience. Finalists are determined based on direct patient feedback, making the recognition a meaningful reflection of the trust patients place in their pharmacy providers.

“Being recognized alongside national organizations and as the only independent finalist validates our belief that personalized, patient-centered care drives better outcomes. We are building a model that combines clinical depth, national reach, and operational flexibility to better serve patients, providers, and partners.” said AJ Patel, Founder and Pharmacy Manager of Accord Specialty Pharmacy.

Accord Specialty Pharmacy supports patients across complex specialty categories, including oncology, rare disease, and infusion, through a clinically driven, high-touch care model designed to improve access, adherence, and outcomes. The company’s approach emphasizes personalized support, responsive care coordination, and strong clinical engagement to help patients navigate complex therapies more effectively. With a growing national footprint and multi-state licensure, Accord is positioned to support patients, providers, and partners across diverse markets.

For more information, visit MMIT Announces Finalists of the 11th Specialty Pharmacy Patient Choice Awards – MMITNetwork.

About Accord Specialty Pharmacy:

Accord Specialty Pharmacy is an ACHC-accredited, multi-state licensed independent specialty pharmacy located in Central Florida, dedicated to delivering high-quality, patient-centered care for individuals managing complex and chronic conditions. Through personalized support, clinical expertise, and a high-touch approach, Accord helps patients navigate every step of their treatment journey. Learn more at www.accordspecialty.com.

CONTACT: contact@accordspecialty.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/accord-specialty-pharmacy-named-finalist-in-mmits-11th-annual-retail-specialty-pharmacy-patient-choice-awards-302752327.html

SOURCE Accord Specialty

Technology

HAIVISION ANNOUNCES VOTING RESULTS FROM 2026 ANNUAL MEETING OF SHAREHOLDERS

Published

2 hours ago

April 23, 2026

MONTRÉAL, April 23, 2026 /CNW/ – Haivision Systems Inc. (“Haivision” or the “Company”) (TSX: HAI) is pleased to announce the voting results from its annual meeting of shareholders held today in a virtual format.

A total of approximately 45.97 % of the issued and outstanding common shares of Haivision were represented at the meeting.

Election of Directors

Each of the six nominated directors of Haivision was elected as director of the Company with the following results:

Director

Votes
For

% Votes
For

Votes
Against

% Votes
Against

Miroslav Wicha

11,110,245

99.26 %

82,583

0.74 %

Harvey Bienenstock

11,155,137

99.66 %

37,691

0.34 %

Robin M. Rush

11,121,855

99.37 %

70,973

0.63 %

Neil Hindle

10,794,005

96.44 %

398,823

3.56 %

Julie Tremblay

10,941,969

97.76 %

250,859

2.24 %

Lee K. Levy II

9,084,418

81.16 %

2,108,410

18.84 %

2. Appointment of Auditors

Deloitte LLP were reappointed auditors of the Company for the ensuing year with 12,492,582 (98.84%) votes cast in favour and 146,406 (1.16%) votes withheld.

3. Approval of the Unallocated Awards under the Company’s Equity Incentive Plan

The Company’s unallocated awards were approved with 8,710,347 (77.82%) votes cast in favour and 2,482,481 (22.18%) votes cast against.

4. Reapproval of Company’s Shareholder Rights Plan

The Company’s shareholder rights plan was approved with 10,572,490 (94.46%) votes cast in favour and 620,338 (5.54%) votes cast against.

Final voting results on all matters voted on at the meeting will be filed under Haivision’s profile on SEDAR+ at www.sedarplus.ca.

About Haivision

Haivision is a leading global provider of mission-critical, real-time video streaming and visual collaboration solutions. Our connected cloud and intelligent edge technologies enable organizations globally to engage audiences, enhance collaboration, and support decision making. We provide high quality, low latency, secure, and reliable live video at a global scale. Haivision open sourced its award-winning SRT low latency video streaming protocol and founded the SRT Alliance to support its adoption. Awarded four Emmys® for Technology and Engineering from the National Academy of Television Arts and Sciences, Haivision continues to fuel the future of IP video transformation. Founded in 2004, Haivision is headquartered in Montreal and Chicago with offices, sales, and support located throughout the Americas, Europe, and Asia. Learn more at haivision.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/haivision-announces-voting-results-from-2026-annual-meeting-of-shareholders-302752318.html

SOURCE Haivision Systems Inc.